FDA Inspection
STRIVE PHARMACEUTICALS INCSTRIVE PHARMACEUTICALS INC – FDA Inspection, Jun 2, 2025
Record Details
This FDA Inspection record concerns STRIVE PHARMACEUTICALS INC, with an inspection on June 2, 2025, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · 93cdfcc5-a5bc-400d-8735-28aab26199d6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1271503
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.63Equipment Design, Size and Location
Full citation text and observation details available on the Dashboard.
Other FDA inspections of STRIVE PHARMACEUTICALS INC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 5, 2025 | Not classified | New Jersey District Office | |
| December 6, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for STRIVE PHARMACEUTICALS INC
- FDA Inspection 1263613 - 2025-03-05
- FDA Inspection 1113157 - 2019-12-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.